耐甲氧苄啶大肠菌群 - Suppr

Suppr

超能文献

Trimethoprim-resistant coliforms.

作者信息

Lacey R W, Bruten D M, Gillespie W A, Lewis E L

出版信息

Lancet. 1972 Feb 19;1(7747):409-10. doi: 10.1016/s0140-6736(72)90857-4.

DOI:10.1016/s0140-6736(72)90857-4

PMID:4110643

Abstract

摘要

相似文献

Trimethoprim-resistant coliforms.耐甲氧苄啶大肠菌群

Lancet. 1972 Feb 19;1(7747):409-10. doi: 10.1016/s0140-6736(72)90857-4.

[In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].[人类病原体对磺胺甲恶唑-甲氧苄啶药物组合的体外敏感性]

Schweiz Med Wochenschr. 1971 Sep 25;101(38):1385-90.

Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.复方新诺明对粪便肠道杆菌的影响：未出现耐药菌株。

J Med Microbiol. 1973 May;6(2):249-52. doi: 10.1099/00222615-6-2-249.

The action of trimethoprim-sulphamethoxazole against urinary pathogens.甲氧苄啶-磺胺甲恶唑对尿路病原体的作用。

Med J Aust. 1972 Feb 5;1(6):263-5.

Determination of bacterial resistance to trimethoprim-sulphamethoxazole using the single disc diffusion method.

Chemotherapy. 1973;18(3):162-8. doi: 10.1159/000221258.

[Antibacterial effect of sulfanilamide combination drugs].[磺胺类复方药物的抗菌作用]

Med Klin. 1972 Dec 8;67(49):1626-31.

[Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].甲氧苄啶-磺胺甲恶唑组合的体外和体内抗菌活性

Antibiotica. 1969 Dec;7(4):250-68.

[Results of treatment with trimethoprim-sulfamethoxazole in nonspecific urinary tract infections in pediatric urology].[甲氧苄啶-磺胺甲恶唑治疗小儿泌尿外科非特异性尿路感染的结果]

Monatsschr Kinderheilkd (1902). 1972 Sep;120(9):346-9.

Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo.甲氧苄啶-磺胺甲恶唑对革兰氏阴性杆菌的协同活性：体内外观察

J Infect Dis. 1973 Nov;128:Suppl:470-7 p. doi: 10.1093/infdis/128.supplement_3.s470.

[The combination sulfamethoxazole-trimethoprim in vitro].[复方磺胺甲恶唑的体外实验]

Zentralbl Bakteriol Orig A. 1972 Sep;221(4):511-26.

引用本文的文献

Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin.输注速率和丙磺舒对人静脉注射头孢西丁的血清水平、肾排泄及耐受性的影响：与头孢噻吩的比较。

Antimicrob Agents Chemother. 1974 Sep;6(3):338-46. doi: 10.1128/AAC.6.3.338.

Molecular characterization of trimethoprim resistance in salmonellas isolated in Sicily, 1985-1988.1985 - 1988年在西西里岛分离的沙门氏菌中三甲氧苄氨嘧啶耐药性的分子特征

Eur J Epidemiol. 1995 Feb;11(1):33-8. doi: 10.1007/BF01719943.

Bacterial resistance to trimethoprim.细菌对甲氧苄啶的耐药性。

Br Med J. 1980 Aug 30;281(6240):571-2.

Trimethoprim resistance in Finland after five years' use of plain trimethoprim.在单纯使用甲氧苄啶五年后芬兰出现的甲氧苄啶耐药性。

Br Med J. 1980 Jan 12;280(6207):72-4. doi: 10.1136/bmj.280.6207.72.

Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.服用复方磺胺甲恶唑或单独服用甲氧苄啶患者粪便菌群的耐药性。

Antimicrob Agents Chemother. 1981 Jan;19(1):33-8. doi: 10.1128/AAC.19.1.33.

Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.金黄色葡萄球菌对磺胺甲恶唑和甲氧苄啶的耐药性。

J Clin Pathol. 1972 Aug;25(8):708-12. doi: 10.1136/jcp.25.8.708.

Faecal flora after prolonged co-trimoxazole treatment.长期复方新诺明治疗后的粪便菌群

Br Med J. 1972 Aug 12;3(5823):416. doi: 10.1136/bmj.3.5823.416-a.

Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis.大肠菌群、金黄色葡萄球菌和粪肠球菌对甲氧苄啶和磺胺类药物耐药性的当前意义。

J Clin Pathol. 1973 Mar;26(3):175-80. doi: 10.1136/jcp.26.3.175.

A reappraisal of the antibacterial action of cotrimoxazole in vitro.复方新诺明体外抗菌作用的重新评估。

J Clin Pathol. 1974 Feb;27(2):87-91. doi: 10.1136/jcp.27.2.87.

Trimethoprim-resistance and its transferability in E. coli isolated from calves treated with trimethoprim-sulphadiazine: a two year study.

J Hyg (Lond). 1973 Dec;71(4):669-77. doi: 10.1017/s0022172400022932.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验